European Brain Council.
Eur J Neurosci. 2011 Mar;33(5):768-818. doi: 10.1111/j.1460-9568.2010.07596.x.
Psychiatric and neurological diseases combined represent a considerable social and economic burden in Europe. A recent study conducted by the European Brain Council (EBC) quantified the 'cost and burden' of major brain diseases in Europe, amounting to €386bn per year. Considering that these costs will increase exponentially in the years to come due to ageing of the European population, it is necessary to act now in order to curb this increase and possibly reverse the trend. Thus, establishing a strong European platform supporting basic and clinical research in neuroscience is needed to confront the economic and social challenge posed by management of brain diseases in European countries. To setup a platform for discussion, EBC published in 2006 a Consensus Document on European Brain Research, describing needs and achievements of research in Europe and presenting proposals for future research programs. Since 2006, European research in neuroscience has advanced tremendously. The present document represents an update elaborated to reflect changes in research priorities and advances in brain research that have taken place since 2006. The same approach and format have been used here as in the previous version. Multinational and multidisciplinary teams have once again come together to express their views, not only on the current strengths in European research, but also on what needs to be done in priority, hoping that this update will inspire policy makers and stakeholders in directing funding for research in Europe.
精神和神经疾病合并在欧洲代表着相当大的社会和经济负担。欧洲脑理事会(EBC)最近进行的一项研究量化了欧洲主要脑部疾病的“成本和负担”,每年达到 3860 亿欧元。考虑到由于欧洲人口老龄化,这些成本在未来几年将呈指数级增长,现在就必须采取行动,以遏制这种增长,并有可能扭转这一趋势。因此,有必要建立一个强大的欧洲平台,支持神经科学的基础和临床研究,以应对欧洲国家管理脑部疾病带来的经济和社会挑战。为了建立一个讨论的平台,EBC 于 2006 年发布了一份关于欧洲脑研究的共识文件,描述了欧洲研究的需求和成就,并提出了未来研究计划的建议。自 2006 年以来,欧洲神经科学研究取得了巨大进展。本文件是对 2006 年以来研究重点变化和脑研究进展的更新阐述。这里使用了与前一版本相同的方法和格式。跨国和多学科团队再次聚集在一起,表达他们的观点,不仅是对欧洲研究当前优势的看法,也是对需要优先考虑的事项的看法,希望这一更新将为决策者和利益相关者提供指导,为欧洲的研究提供资金。